Cereal and nonfat milk support muscle recovery following exercise

All authors are with the Exercise Physiology and Metabolism Laboratory Department of Kinesiology and Health Education The University of Texas at Austin Austin, TX, USABackground: This study compared the effects of ingesting cereal and nonfat milk (Cereal) and a carbohydrate-electrolyte sports drink (Drink) immediately following endurance exercise on muscle glycogen synthesis and the phosphorylation state of proteins controlling protein synthesis: Akt, mTOR, rpS6 and eIF4E. -- Methods: Trained cyclists or triathletes (8 male: 28.0 ± 1.6 yrs, 1.8 ± 0.0 m, 75.4 ± 3.2 kg, 61.0 ± 1.6 ml O2•kg-1•min-1; 4 female: 25.3 ± 1.7 yrs, 1.7 ± 0.0 m, 66.9 ± 4.6 kg, 46.4 ± 1.2 mlO2•kg-1•min-1) completed two randomly-ordered trials serving as their own controls. After 2 hours of cycling at 60–65% VO2MAX, a biopsy from the vastus lateralis was obtained (Post0), then subjects consumed either Drink (78.5 g carbohydrate) or Cereal (77 g carbohydrate, 19.5 g protein and 2.7 g fat). Blood was drawn before and at the end of exercise, and at 15, 30 and 60 minutes after treatment. A second biopsy was taken 60 minutes after supplementation (Post60). Differences within and between treatments were tested using repeated measures ANOVA. -- Results: At Post60, blood glucose was similar between treatments (Drink 6.1 ± 0.3, Cereal 5.6 ± 0.2 mmol/L, p < .05), but after Cereal, plasma insulin was significantly higher (Drink 123.1 ± 11.8, Cereal 191.0 ± 12.3 pmol/L, p < .05), and plasma lactate significantly lower (Drink 1.4 ± 0.1, Cereal 1.00 ± 0.1 mmol/L, p < .05). Except for higher phosphorylation of mTOR after Cereal, glycogen and muscle proteins were not statistically different between treatments. Significant Post0 to Post60 changes occurred in glycogen (Drink 52.4 ± 7.0 to 58.6 ± 6.9, Cereal 58.7 ± 9.6 to 66.0 ± 10.0 μmol/g, p < .05) and rpS6 (Drink 17.9 ± 2.5 to 35.2 ± 4.9, Cereal 18.6 ± 2.2 to 35.4 ± 4.4 %Std, p < .05) for each treatment, but only Cereal significantly affected glycogen synthase (Drink 66.6 ± 6.9 to 64.9 ± 6.9, Cereal 61.1 ± 8.0 to 54.2 ± 7.2%Std, p < .05), Akt (Drink 57.9 ± 3.2 to 55.7 ± 3.1, Cereal 53.2 ± 4.1 to 60.5 ± 3.7 %Std, p < .05) and mTOR (Drink 28.7 ± 4.4 to 35.4 ± 4.5, Cereal 23.0 ± 3.1 to 42.2 ± 2.5 %Std, p < .05). eIF4E was unchanged after both treatments. -- Conclusion: These results suggest that Cereal is as good as a commercially-available sports drink in initiating post-exercise muscle recovery.Kinesiology and Health [email protected]

Outliers involving the Poly(A) effect among highly-expressed genes in microarrays

BACKGROUND: The Poly(A) effect is a cross-hybridization artifact in which poly(T)-containing molecules, which are produced by the reverse transcription of a poly(A)(+ )RNA mixture, bind promiscuously to the poly(A) stretches of the DNA in microarray spots. It is customary to attempt to block such hybridization by adding poly(A) to the hybridization solution. This note describes an experiment intended to evaluate circumstances under which the blocking procedure may not have been successful. RESULTS: The experiment involves a spot-by-spot comparison between the hybridization signals obtained by hybridizing a microarray to: (1) end-labeled oligo(dT), versus, (2) cDNA prepared from muscle tissue. We found that the blocking appears to be successful for the vast majority of microarray spots, as evidenced by the weakness of the correlation between signals (1) and (2). However, we found that for microarray spots having oligo(dT) hybridization levels greater than a certain threshold, the blocking might be ineffective or incomplete, as evidenced by an exceptionally strong signal (2) whenever signal (1) is greater than the threshold. CONCLUSION: The PolyA effect may be more subtle than simply a hybridization signal that is proportional to the PolyA content of each microarray spot. It may instead be present only in spots that hybridize oligo(dT) greater than some threshold level. The strong signal generated at these "outlier" spots by cDNA probes might be due to the formation of hybridization heteropolymers

Taxing audit markets and reputation: An examination of the U.S. tax shelter controversy

From 2002 to 2007, the nation\u27s largest CPA firms faced allegations of illegal activity related to the sale of tax shelters: EY, KPMG and PwC paid fines; KPMG was investigated by a federal grand jury; and EY faced a criminal inquiry. These shelter events occurred shortly after the 2002 collapse of Arthur Andersen, when policy makers were concerned about audit market concentration. This is the first paper to provide a chronological summary of how the tax shelter controversy started and ended. We investigate the stock market reaction to tax shelter news developments between 2003 and 2005 to make inferences about the market\u27s view of audit competition and CPA firm reputation. Our results are consistent with market concern over large audit firm concentration, evidenced by large negative returns for clients of all audit providers upon the KPMG grand jury investigation announcement. We also find that tax shelter activities impact both the reputation of the accounting profession and the individual CPA firms marketing tax shelter products. © 2014 Elsevier Inc

Effect of a Low Carbohydrate-Moderate Protein Supplement on Endurance Performance in Female Athletes

Previous research has shown that consuming a carbohydrate supplement during prolonged endurance exercise improves performance compared to water or placebo. The addition of protein to traditional carbohydrate supplement has been shown to further improve perfomance beyond that of carbohydrate alone. However, few investigations have explored the effect of adding protein to a supplement containing a low carbohydrate concentration. PURPOSE: To investigate if a low carbohydrate and moderate protein supplement, provided during prolonged variable intensity exercise, would improve time to exhaustion in comparison to a traditional carbohydrate supplement. METHODS: Fourteen (n = 14) trained females cyclists and triathletes (30.4 ±1.6 yrs, 2.90 ± 0.15 L⋅min¬-1) cycled on two different occasions for three hours at intensities varying between 45% - 70% VO2max. After three hours, the intensity was increased (average 72.5 % VO2max) and held until exhaustion. Exhaustion was defined as the point at which subjects could no longer hold cadence above 60RPM. Supplements (275ml) were provided every 20 min during exercise and were composed of a 3% carbohydrate/1.2% protein mix (CHO+PRO) or a 6% carbohydrate-only (CHO). The CHO+PRO treatment contained a mixture of glucose (dextrose), maltodextrin and fructose, and whey protein isolate. The CHO treatment was composed of dextrose. CHO+PRO contained half the carbohydrate content and 30% less calories in comparison to CHO. RESULTS: Time to exhaustion (TTE) was significantly greater with CHO+PRO in comparison to CHO (49.94 ± 7.01 vs 42.36 ± 6.21 min, respectively, p = 0.039). CONCLUSIONS: The above result suggests that addition of a moderate protein to a low carbohydrate supplement enhances performance in endurance trained females above that of carbohydrate alone. Improvement in performance occurred despite a lower carbohydrate and caloric content. It is unknown whether the greater performance seen with CHO+PRO was a result of the added protein, the use of a mixture of carbohydrate sources (glucose, maltodextrin and fructose), or their combination

Effects of Chocolate Milk Supplementation on Recovery from Cycling Exercise and Subsequent Time Trial Performance

PURPOSE: Supplementing with carbohydrate plus protein following strenuous endurance exercise has been found to improve both recovery and subsequent aerobic endurance performance beyond that of a carbohydrate supplement alone. The purpose of the present study was to compare the effects of chocolate milk (CM), an isocaloric carbohydrate only supplement (CHO), and placebo (PLA) on markers of endurance exercise recovery and subsequent time trial performance in trained cyclists. METHODS: Ten trained male and female cyclists (5 males, 5 females) performed 3 trials in which they first cycled for 1.5 h at 70% of VO2max, followed by 10 min of intervals that alternated 45% and 90% VO2max. They then recovered in the laboratory for 4 h, and performed a 40 km time trial (TT). The supplements were provided immediately after the first bout and 2 h into the recovery period. Treatments were administered using a double-blind randomized design. RESULTS: TT time was significantly shorter in CM than CHO and PLA (79.43±2.11 vs. 85.74±3.44 and 86.92±3.28 min, respectively, p=\u3c.05). Significant treatment differences were found for plasma insulin, glucose, free fatty acids (FFA) and glycerol. Plasma insulin levels were significantly lower in CM than CHO at recovery time points R45 (47.30±10.54 vs. 58.71±6.01 &#;U/ml, p\u3c.05), R120 (14.32±1.34 vs. 22.53±3.37 &#;U/ml, p\u3c.05) and REnd (15.57±1.53 vs. 34.35±4.55 &#;U/ml, p\u3c.05). Plasma glucose was significantly lower in CM than CHO at recovery time points R45 (76.61±3.08 vs. 101.65±3.47 mg/dL, p\u3c.05) and R120 (74.72±2.22 vs. 81.46±4.87 mg/dL, p\u3c.05). While FFA and glycerol were both higher in PLA than in CM and CHO overall (p\u3c.05 for both), FFA and glycerol were higher in CM than in CHO (p\u3c.05 for both) during recovery and at TTEnd. Blood lactate was significantly higher at R45 and TTEnd in both CM and CHO than in PLA, but no differences were found between CM and CHO. No significant treatment differences were found for myoglobin, CPK, cortisol, and 5 pro- and anti-inflammatory cytokines (TNF-&#;, IL-6, IL-10, IL-8, and IL-1Ra). CONCLUSIONS: Chocolate milk provided during recovery can improve subsequent time trial performance in trained cyclists more effectively than an isocaloric CHO supplement. This may be due to a faster rate of muscle glycogen resynthesis

4β-Methyl-5-(3-hydroxyphenyl)morphan Opioid Agonist and Partial Agonist Derived from a 4β-Methyl-5-(3-hydroxyphenyl)morphan Pure Antagonist

In previous studies we reported that addition of 7α-acylamino groups to N-phenylpropyl-4β-methyl-5-(3-hydroxyphenyl)morphan (4) led to compounds that were pure opioid receptor antagonists. In contrast to these findings we report in this study that addition of a 7α-amino (5a), 7α-alkylamino (5b–e), or 7α-dialkylamino (5f–h) group to 4 leads to opioid receptor ligands with varying degrees of agonist/antagonist activity. The 7α-amino and 7α-methylamino analogues were full agonists at the μ and δ receptors and antagonists at the κ receptor. The 7α-cyclopropylmethylamino analogue 5h was a full agonist at the μ receptor with weaker agonist activity at the δ and κ receptors. Whereas the addition of a 7α-acylamino group to the pure non-selective opioid receptor antagonist N-phenylpropyl-4β-methyl-5-(3-hydroxyphenyl)morphan (4) led to κ selective pure opioid receptor antagonist, the addition of a 7α-amino, 7α-alkylamino or 7α-dialkylamino group to 4 leads to opioid ligands that are largely μ or δ agonist with mixed agonist/antagonist properties

Envisioning a World Beyond APCs/BPCs

This archival page includes documents and recordings related to the international symposium, “Envisioning a World Beyond APCs/BPCs,” held in Lawrence, Kansas, on Thursday and Friday, November 17-18. The presenters were a group of 18 internationally respected scholars, publishers, university librarians, and executives from foundations and organizations, who were asked to participate in a discussion about current models available for achieving an expansive, inclusive, and balanced worldwide open publishing ecosystem. The symposium was co-sponsored by the University of Kansas Libraries, Open Access Network (a project of K|N Consultants), Allen Press, SPARC, and ARL. The materials included here are the symposium schedule, recordings of Parts 1 and 2 of the Nov. 17 livestream, a transcript of the livestream, and team proposals originating from the Nov. 18 morning session.This symposium was sponsored by the University of Kansas Libraries, Open Access Network (a project of K|N Consultants), Allen Press, and SPARC

Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species.

Dendritic cells (DCs) are professional antigen-presenting cells that hold great therapeutic potential. Multiple DC subsets have been described, and it remains challenging to align them across tissues and species to analyze their function in the absence of macrophage contamination. Here, we provide and validate a universal toolbox for the automated identification of DCs through unsupervised analysis of conventional flow cytometry and mass cytometry data obtained from multiple mouse, macaque, and human tissues. The use of a minimal set of lineage-imprinted markers was sufficient to subdivide DCs into conventional type 1 (cDC1s), conventional type 2 (cDC2s), and plasmacytoid DCs (pDCs) across tissues and species. This way, a large number of additional markers can still be used to further characterize the heterogeneity of DCs across tissues and during inflammation. This framework represents the way forward to a universal, high-throughput, and standardized analysis of DC populations from mutant mice and human patients

Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains

The human immunity-related GTPase M (IRGM) has been shown to be critically involved in regulating autophagy as a means of disposing cytosolic cellular structures and of reducing the growth of intracellular pathogens in vitro. This includes Mycobacterium tuberculosis, which is in agreement with findings indicating that M. tuberculosis translocates from the phagolysosome into the cytosol of infected cells, where it becomes exposed to autophagy. To test whether IRGM plays a role in human infection, we studied IRGM gene variants in 2010 patients with pulmonary tuberculosis (TB) and 2346 unaffected controls. Mycobacterial clades were classified by spoligotyping, IS6110 fingerprinting and genotyping of the pks1/15 deletion. The IRGM genotype −261TT was negatively associated with TB caused by M. tuberculosis (OR 0.66, CI 0.52–0.84, Pnominal 0.0009, Pcorrected 0.0045) and not with TB caused by M. africanum or M. bovis (OR 0.95, CI 0.70–1.30. P 0.8). Further stratification for mycobacterial clades revealed that the protective effect applied only to M. tuberculosis strains with a damaged pks1/15 gene which is characteristic for the Euro-American (EUAM) subgroup of M. tuberculosis (OR 0.63, CI 0.49–0.81, Pnominal 0.0004, Pcorrected 0.0019). Our results, including those of luciferase reporter gene assays with the IRGM variants −261C and −261T, suggest a role for IRGM and autophagy in protection of humans against natural infection with M. tuberculosis EUAM clades. Moreover, they support in vitro findings indicating that TB lineages capable of producing a distinct mycobacterial phenolic glycolipid that occurs exclusively in strains with an intact pks1/15 gene inhibit innate immune responses in which IRGM contributes to the control of autophagy. Finally, they raise the possibility that the increased frequency of the IRGM −261TT genotype may have contributed to the establishment of M. africanum as a pathogen in the West African population

Environmental risk factors for dementia: a systematic review

Background - Dementia risk reduction is a major and growing public health priority. While certain modifiable risk factors for dementia have been identified, there remains a substantial proportion of unexplained risk. There is evidence that environmental risk factors may explain some of this risk. Thus, we present the first comprehensive systematic review of environmental risk factors for dementia. Methods - We searched the PubMed and Web of Science databases from their inception to January 2016, bibliographies of review articles, and articles related to publically available environmental data. Articles were included if they examined the association between an environmental risk factor and dementia. Studies with another outcome (for example, cognition), a physiological measure of the exposure, case studies, animal studies, and studies of nutrition were excluded. Data were extracted from individual studies which were, in turn, appraised for methodological quality. The strength and consistency of the overall evidence for each risk factor identified was assessed. Results - We screened 4784 studies and included 60 in the review. Risk factors were considered in six categories: air quality, toxic heavy metals, other metals, other trace elements, occupational-related exposures, and miscellaneous environmental factors. Few studies took a life course approach. There is at least moderate evidence implicating the following risk factors: air pollution; aluminium; silicon; selenium; pesticides; vitamin D deficiency; and electric and magnetic fields. Conclusions - Studies varied widely in size and quality and therefore we must be circumspect in our conclusions. Nevertheless, this extensive review suggests that future research could focus on a short list of environmental risk factors for dementia. Furthermore, further robust, longitudinal studies with repeated measures of environmental exposures are required to confirm these associations